These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 33387364)
1. Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma. Chapel DB; Dubuc AM; Hornick JL; Sholl LM Histopathology; 2021 Jun; 78(7):1032-1042. PubMed ID: 33387364 [TBL] [Abstract][Full Text] [Related]
2. MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma. Chapel DB; Schulte JJ; Berg K; Churg A; Dacic S; Fitzpatrick C; Galateau-Salle F; Hiroshima K; Krausz T; Le Stang N; McGregor S; Nabeshima K; Husain AN Mod Pathol; 2020 Feb; 33(2):245-254. PubMed ID: 31231127 [TBL] [Abstract][Full Text] [Related]
3. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Illei PB; Rusch VW; Zakowski MF; Ladanyi M Clin Cancer Res; 2003 Jun; 9(6):2108-13. PubMed ID: 12796375 [TBL] [Abstract][Full Text] [Related]
4. Concordance between CDKN2A homozygous deletion and MTAP immunohistochemical loss in fluoroedenite-induced pleural mesothelioma: An immunohistochemical and molecular study on a single-institution series. Broggi G; Massimino M; Failla M; Filetti V; Rapisarda V; Ledda C; Lombardo C; Loreto C; Vigneri P; Caltabiano R Pathol Res Pract; 2024 Jul; 259():155350. PubMed ID: 38781764 [TBL] [Abstract][Full Text] [Related]
5. A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas. Brcic L; Le Stang N; Gallob F; Pissaloux D; Sequeiros R; Paindavoine S; Pairon JC; Karanian M; Dacic S; Girard N; Churg A; Tirode F; Galateau-Salle F Arch Pathol Lab Med; 2023 Mar; 147(3):313-322. PubMed ID: 35738002 [TBL] [Abstract][Full Text] [Related]
6. [Methylthioadenosine phosphorylase and p16 as surrogate diagnostic markers for CDKN2A homozygous deletion in brain tumors]. Wang SN; Wang W; Zhang XW; Zhang YQ; Xiong YL; Liu L; Teng LH Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):439-445. PubMed ID: 38678323 [No Abstract] [Full Text] [Related]
7. Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma. Febres-Aldana CA; Chang JC; Jungbluth AA; Adusumilli PS; Bodd FM; Frosina D; Geronimo JA; Hernandez E; Irawan H; Offin MD; Rekhtman N; Travis WD; Vanderbilt C; Zauderer MG; Zhang Y; Ladanyi M; Yang SR; Sauter JL Mod Pathol; 2024 Mar; 37(3):100420. PubMed ID: 38185249 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens. Berg KB; Churg AM; Cheung S; Dacic S Cancer Cytopathol; 2020 Feb; 128(2):126-132. PubMed ID: 31821740 [TBL] [Abstract][Full Text] [Related]
9. The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature. Hassan A; Prabhakaran S; Pulford E; Hocking AJ; Godbolt D; Ziad F; Pandita A; Wessels A; Hussey M; Russell PA; Klebe S Pathology; 2024 Aug; 56(5):662-670. PubMed ID: 38789301 [TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma. Brich S; Bozzi F; Perrone F; Tamborini E; Cabras AD; Deraco M; Stacchiotti S; Dagrada GP; Pilotti S Mod Pathol; 2020 Feb; 33(2):217-227. PubMed ID: 31570769 [TBL] [Abstract][Full Text] [Related]
11. Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas. Berg KB; Dacic S; Miller C; Cheung S; Churg A Arch Pathol Lab Med; 2018 Dec; 142(12):1549-1553. PubMed ID: 30059257 [TBL] [Abstract][Full Text] [Related]
12. CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival. Krasinskas AM; Bartlett DL; Cieply K; Dacic S Mod Pathol; 2010 Apr; 23(4):531-8. PubMed ID: 20081810 [TBL] [Abstract][Full Text] [Related]
13. Correlation of MTAP Immunohistochemistry With CDKN2A Status Assessed by Fluorescence In Situ Hybridization and Clinicopathological Features in CNS WHO Grade 2 and 3 Meningiomas: A Single Center Cohort Study. Sasaki S; Takeda M; Hirose T; Fujii T; Itami H; Uchiyama T; Morita K; Matsuda R; Yamada S; Nakagawa I; Ohbayashi C J Neuropathol Exp Neurol; 2022 Jan; 81(2):117-126. PubMed ID: 34897475 [TBL] [Abstract][Full Text] [Related]
14. Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma/sarcomatoid pleural mesothelioma with desmoplastic features. Sa-Ngiamwibool P; Hamasaki M; Kinoshita Y; Matsumoto S; Sato A; Tsujimura T; Kasai T; Hiroshima K; Kushitani K; Takeshima Y; Kawahara K; Iwasaki A; Nabeshima K Ann Diagn Pathol; 2022 Oct; 60():152004. PubMed ID: 35797798 [TBL] [Abstract][Full Text] [Related]
15. Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma. Kinoshita Y; Hamasaki M; Yoshimura M; Matsumoto S; Iwasaki A; Nabeshima K Mod Pathol; 2020 Feb; 33(2):235-244. PubMed ID: 31231129 [TBL] [Abstract][Full Text] [Related]
16. Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report. Minami K; Jimbo N; Tanaka Y; Hokka D; Miyamoto Y; Itoh T; Maniwa Y Virchows Arch; 2020 Mar; 476(3):469-473. PubMed ID: 31667596 [TBL] [Abstract][Full Text] [Related]
17. Sarcomatoid mesothelioma originating from mesothelioma in situ: are methylthioadenosine phosphorylase loss and CDKN2A homozygous deletion poor prognostic factors for preinvasive mesothelioma? Nishikubo M; Jimbo N; Tanaka Y; Tachihara M; Itoh T; Maniwa Y Virchows Arch; 2022 Aug; 481(2):307-312. PubMed ID: 35043235 [TBL] [Abstract][Full Text] [Related]
18. Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma. Satomi K; Ohno M; Matsushita Y; Takahashi M; Miyakita Y; Narita Y; Ichimura K; Yoshida A Mod Pathol; 2021 Apr; 34(4):688-700. PubMed ID: 33077924 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry. Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Iwasaki A; Okamoto T; Oda Y; Honda H; Nabeshima K Lung Cancer; 2017 Feb; 104():98-105. PubMed ID: 28213009 [TBL] [Abstract][Full Text] [Related]
20. Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma. Şeker NS; Tekin E; Ak G; Metintaş M; Metintaş S; Dündar E Diagn Cytopathol; 2024 Apr; 52(4):211-216. PubMed ID: 38243885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]